|
1
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jabbour E, Deininger M and Hochhaus A:
Management of adverse events associated with tyrosine kinase
inhibitors in the treatment of chronic myeloid leukemia. Leukemia.
25:201–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Braidotti P, Nuciforo PG, Mollenhauer J,
Poustka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S
and Pietra GG: DMBT1 expression is down-regulated in breast cancer.
BMC Cancer. 4:462004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imai MA, Moriya T, Imai FL, Shiiba M,
Bukawa H, Yokoe H, Uzawa K and Tanzawa H: Down-regulation of DMBT1
gene expression in human oral squamous cell carcinoma. Int J Mol
Med. 15:585–589. 2005.PubMed/NCBI
|
|
7
|
Hernandez BY, Green MD, Cassel KD,
Pobutsky AM, Vu V and Wilkens LR: Preview of Hawaii cancer facts
and figures 2010. Hawaii Med J. 69:223–224. 2010.PubMed/NCBI
|
|
8
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mazzaferri EL and Jhiang SM: Long-term
impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 97:418–428. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gagliardi PA, Puliafito A and Primo L:
PDK1: At the crossroad of cancer signaling pathways. Semin Cancer
Biol. 48:27–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leroux AE, Schulze JO and Biondi RM: AGC
kinases, mechanisms of regulation and innovative drug development.
Semin Cancer Biol. 48:1–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arsenic R: Immunohistochemical analysis of
PDK1 expression in breast cancer. Diagn Pathol. 9:822014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han L, Zhang G, Zhang N, Li H, Liu Y, Fu A
and Zheng Y: Prognostic potential of microRNA-138 and its target
mRNA PDK1 in sera for patients with non-small cell lung cancer. Med
Oncol. 31:1292014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferro R and Falasca M: Emerging role of
the KRAS-PDK1 axis in pancreatic cancer. World J Gastroenterol.
20:10752–10757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng N, Ding X, Sun A and Jahan R: PDK1
activity regulates proliferation, invasion and growth of
hemangiomas. Cell Physiol Biochem. 36:1903–1910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lian S, Shao Y, Liu H, He J, Lu W, Zhang
Y, Jiang Y and Zhu J: PDK1 induces JunB, EMT, cell migration and
invasion in human gallbladder cancer. Oncotarget. 6:29076–29086.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mollenhauer J, Holmskov U, Wiemann S,
Krebs I, Herbertz S, Madsen J, Kioschis P, Coy JF and Poustka A:
The genomic structure of the DMBT1 gene: evidence for a region with
susceptibility to genomic instability. Oncogene. 18:6233–6240.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mollenhauer J, Wiemann S, Scheurlen W,
Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A:
DMBT1, a new member of the SRCR superfamily, on chromosome
10q25.3–26.1 is deleted in malignant brain tumours. Nat Genet.
17:32–39. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith HA and Kang Y: The
metastasis-promoting roles of tumor-associated immune cells. J Mol
Med (Berl). 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng H, Gao YB, Wang HF, Jin XL and Xiao
JC: Expression of deleted in malignant brain tumours 1 (DMBT1)
relates to the proliferation and malignant transformation of
hepatic progenitor cells in hepatitis B virus-related liver
diseases. Histopathology. 60:249–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du J, Guan M, Fan J and Jiang H: Loss of
DMBT1 expression in human prostate cancer and its correlation with
clinical progressive features. Urology. 77:509.e9–509.e13. 2011.
View Article : Google Scholar
|
|
22
|
Zöchbauer-Müller S, Fong KM, Virmani AK,
Geradts J, Gazdar AF and Minna JD: Aberrant promoter methylation of
multiple genes in non-small cell lung cancers. Cancer Res.
61:249–255. 2001.PubMed/NCBI
|
|
23
|
Mollenhauer J, Herbertz S, Helmke B,
Kollender G, Krebs I, Madsen J, Holmskov U, Sorger K, Schmitt L,
Wiemann S, et al: Deleted in Malignant Brain Tumors 1 is a
versatile mucin-like molecule likely to play a differential role in
digestive tract cancer. Cancer Res. 61:8880–8886. 2001.PubMed/NCBI
|
|
24
|
Ridnour LA, Cheng RY, Switzer CH, Heinecke
JL, Ambs S, Glynn S, Young HA, Trinchieri G and Wink DA: Molecular
pathways: toll-like receptors in the tumor microenvironment-poor
prognosis or new therapeutic opportunity. Clin Cancer Res.
19:1340–1346. 2013. View Article : Google Scholar : PubMed/NCBI
|
